☰
×
News
Top 20
Insights
Insights+
ThoughtSpot
Interviews
Viewpoints
Exclusive
Spotlight
Events
Magazine
Bespoke
Newswire
x
Search
Search here
Search here
Subscribe Now
Humacyte
Humacyte Reports BLA Acceptance with Priority Review by the US FDA for Human Aacelluar Vessel to Treat Vascular Trauma
February 12, 2024
Laura Niklason, Founder, President, and CEO of Humacyte Shares her Views from the HAV™ Coronary Artery Bypass Graft Data Presented...
February 28, 2023
Load more...
Back to Home
Modal title
×
Modal body text goes here.